Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962710 · ClinicalTrials.gov registry record
FreeStyle Libre 3 Continuous Glucose Monitoring System
A clinical trial, sponsored by Abbott Diabetes Care.
- Terminated
- Registry status
- 7
- Enrollment target
NCT05962710: Clinical Trial study, sponsored by Abbott Diabetes Care.
NCT05962710 is a clinical trial that was terminated before completion, run by Abbott Diabetes Care. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05962710 was terminated before completion, sponsored by Abbott Diabetes Care.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.
Primary Outcome
System Performance will be characterized with respect to YSI reference venous plasma measurements
Interventions
- DEVICE FreeStyle Libre 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-01-27 |
| Est. Completion | 2023-01-31 |
Why NCT05962710 stopped before completion
NCT05962710 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre 3 is the first listed.
NCT05962710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05962710 about?
NCT05962710 is a clinical study titled "FreeStyle Libre 3 Continuous Glucose Monitoring System". The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.
What is the current status of trial NCT05962710?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2023-01-27. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT05962710?
The interventions under investigation include: FreeStyle Libre 3 (DEVICE).
Who is sponsoring clinical trial NCT05962710?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI